AlphaCentric Advisors »

AtriCure shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of AtriCure (ATRC) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in AtriCure

Tip: Access up to 7 years of quarterly data

All positions including AtriCure held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AtriCure by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $796k 26k 30.56

More positions owned by AlphaCentric Advisors

Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Abbvie (ABBV)
Merck & Co (MRK)
Thermo Fisher Scientific (TMO)
Astrazeneca Sponsored Adr (AZN)
Novo-nordisk A S Adr (NVO)
Globus Med Cl A (GMED)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Intuitive Surgical Com New (ISRG)
Lamar Advertising Cl A (LAMR)
Boston Scientific Corporation (BSX)

View all positions for AlphaCentric Advisors

Top funds holding AtriCure

Vanguard Group
Wellington Management Company
BlackRock
Alliancebernstein
Hood River Capital Management
Macquarie Group
Champlain Investment Partners
State Street Corporation
Neuberger Berman Group
Geode Capital Management
First Light Asset Management
Jennifer Ranahan
Dimensional Fund Advisors
Kennedy Capital Management
Goldman Sachs Group

View all funds holding AtriCure